BIT TRADE GLOBALPUBLIC DOCUMENTATION
How resource contributions might become value

Economic model

Public information edition 0.1 · 20 October 2026 · Blackmore Technology Group Limited
Document status: Public explanatory draft. Engineering and legal status must be independently verified before relying on any operating or investment claim. No securities are offered here.

From an authorized contribution to an economic asset

Data does not have a guaranteed unit price. Value may arise from freshness, quality, coverage, uniqueness, utility, legal rights, verification, buyer demand and reproducibility. Processing and customer acquisition also have costs.

Distinct cash flows

Activity Who pays? What is received?
Data licence or research service Commercial customer Permitted use of an asset or an analysis
Contributor payout Operating entity under contract Contributor receives a defined entitlement, if earned
Investment subscription Eligible investor An independently defined security issued lawfully
Investor distribution Issuer, after applicable approvals Cash or other entitlement only if legitimately declared and funded

Investment subscriptions are not sales revenue. A simulated wallet balance is not a verified bank receipt. An issuer's hypothetical margin is not necessarily distributable profit.

Valuation principles

An asset-based valuation may examine real licence agreements, cash flow, market comparables, replacement cost, quality of rights, expiry, concentration, defects and independent performance evidence. Any valuation should include sensitivity analysis; a proposed asking price is not a verified market value.

Fee transparency

The dossier considers a commercial data-rights fee of 2.9% plus C$0.30 per transaction; this remains a proposal, not an adopted public tariff. Payment-processor fees and exchange fees must be distinguished. Microtransactions can be uneconomic under per-transaction minimums.

What would prove the model?

Repeat customers, independently reconciled collections, qualified products with enforceable usage rights, transparent cost allocations and actual contributor payouts—not just impressive laboratory counts or projections.